{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:05:04Z","timestamp":1789542304891,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11739-026-04461-4","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:56:46Z","timestamp":1784721406000},"page":"1929-1932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction-associated steatotic liver disease (MASLD): a growing global health priority and a real challenge for the internist"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6498","authenticated-orcid":false,"given":"Marcello","family":"Persico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"1","key":"4461_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.hep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wong VWS, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, ShihaG TC, Yki-J\u00e4rvinenH FJG, Gr\u00f8nb\u00e6k H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, RatziuV GJ (2020) A new definition for metabolic dysfunction associated fatty liver disease. J Hepatol 73(1):202\u2013220. https:\/\/doi.org\/10.1016\/j.hep.2020.03.039","journal-title":"J Hepatol"},{"issue":"1","key":"4461_CR2","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/jlr.2023.100485","volume":"65","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Sookoian S (2024) NAFLD to MASLD: updated naming anddiagnosis criteria for fatty liver disease. J Lipid Res 65(1):100485. https:\/\/doi.org\/10.1016\/jlr.2023.100485","journal-title":"J Lipid Res"},{"issue":"1","key":"4461_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease- Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"8","key":"4461_CR4","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","volume":"21","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Wong G, Anstee QM, Henry L (2023) The global burden of Liver disease. Clin Gastroenterol Hepatol 21(8):1978\u20131991. https:\/\/doi.org\/10.1016\/j.cgh.2023.04.015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"4461_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10(11):666\u2013690. https:\/\/doi.org\/10.1038\/nrgastro.2013.171","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"4461_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104","journal-title":"Nat Med"},{"issue":"5","key":"4461_CR7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR (2010) Evolution of inflammation in NAFLD: the multiple parallel hits. Hepatology 52(5):1836\u20131846","journal-title":"Hepatology"},{"issue":"1","key":"4461_CR8","doi-asserted-by":"publisher","first-page":"328357","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of NAFLD: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"2","key":"4461_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F (2015) Liver Fibrosis, but no other histologic features is associated with long- term outcomes of patients with NAFLD. Stage mortality NAFLD. Gastroenterology 149(2):389\u2013397. https:\/\/doi.org\/10.1053\/j.gastro.2015.04043","journal-title":"Stage mortality NAFLD. Gastroenterology"},{"issue":"5","key":"4461_CR10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stai P, Wong VWS, Kechagias S, Huitcrants R, Loomba R (2017) Increased risk of mortality by fibrosis stage in NAFLD: systematic review and meta-analysis. Hepatology 65(5):1557\u20131565. https:\/\/doi.org\/10.1002\/hep.29085","journal-title":"Hepatology"},{"issue":"12","key":"4461_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JCC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to NAFLD. Nat Genet 40(12):1461\u20131465. https:\/\/doi.org\/10.1038\/ng.257","journal-title":"Nat Genet"},{"issue":"11","key":"4461_CR12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/J.c.met.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M (2022) Gut-liver axis: Pathophysiologic concepts and clinical implications. Cell Metab 34(11):1700\u20131718. https:\/\/doi.org\/10.1016\/J.c.met.2022.09.017","journal-title":"Cell Metab"},{"key":"4461_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/eclinm.2026.103921","author":"B Bromfield","year":"2026","unstructured":"Bromfield B, Weiss JC, Gheewalla G, Feldman T, Mitten EK, Portincasa P, Baffy G (2026) Prediction of trajectories and outcomes in early-stage metabolic dysfunction-associated steatotic liver disease: a narrative review. e Cli Med. https:\/\/doi.org\/10.1016\/eclinm.2026.103921","journal-title":"e Cli Med"},{"issue":"5","key":"4461_CR14","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R (2019) Non-invasive assessment of liver disease in patients with NAFLD. Gastroenterology 156(5):1264\u20131281. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","journal-title":"Gastroenterology"},{"key":"4461_CR15","doi-asserted-by":"publisher","unstructured":"EASL \u2013 EASD \u2013 EASO Clinical Practice Clinical Practice Guidelines of the Management of MAFLD. J Hepatol 81(3): 492\u2013542. https:\/\/doi.org\/10.1016\/j.hep.1014.04.031.","DOI":"10.1016\/j.hep.1014.04.031"},{"key":"4461_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112209","volume":"224","author":"E Han","year":"2025","unstructured":"Han E, Woo SY, Jeon JY, Kang ES, Cha BS, Lee BW, Lee YH (2025) Impact of physical activities in metabolic disfunction associated steatotic liver disease, sarcopenia and cardiovascular disease. Diabetes Res Clin Pract 224:112209. https:\/\/doi.org\/10.1016\/j.diabres.2025.112209","journal-title":"Diabetes Res Clin Pract"},{"key":"4461_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2026.106672","volume":"61","author":"J Troisi","year":"2026","unstructured":"Troisi J, Torre P, Schiavo L, Motta BM, Lombardi M, Festa M, Sarcina T, Masarone M, Persico M (2026) Weight loss-induced metabolic remodeling in metabolic dysfunction-associated steatotic liver disease: a cohort study stratified by genetic risk. Clin Nutr 61:106672. https:\/\/doi.org\/10.1016\/j.clnu.2026.106672","journal-title":"Clin Nutr"},{"issue":"2","key":"4461_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, Friedman SL, Diago M, Romero-Gomez M (2015) Weight loss through lyfestyle mdification significantly reduces features of nonalcoholic Steatohepatitis. Gastroenterology 149(2):367\u2013378. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.005","journal-title":"Gastroenterology"},{"key":"4461_CR19","doi-asserted-by":"publisher","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. NAFLD and risk of incident cardiovascular disease: a meta-analysis. J Hepato 65(3): 589\u2013600. https:\/\/doi.org\/10.1016\/j.hep.2026.05013.","DOI":"10.1016\/j.hep.2026.05013"},{"issue":"1 suppl","key":"4461_CR20","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G (2015) NAFLD: a multisystem disease. J Hepatol 62(1 suppl):S47-64","journal-title":"J Hepatol"},{"issue":"2","key":"4461_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.hep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke F, Puenguel T, Loomba R, Friedman SL (2023) An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. Hepatol 79(2):552\u2013566. https:\/\/doi.org\/10.1016\/j.hep.2023.03.038","journal-title":"Hepatol"},{"issue":"5","key":"4461_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jhep.2022.12.025","volume":"78","author":"V Ratziu","year":"2023","unstructured":"Ratziu V, Charlton M (2023) Rational combination therapy for MASH: Insight form clinical trials and error. J Hepatol 78(5):1073\u20131079","journal-title":"J Hepatol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04461-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:34:45Z","timestamp":1789540485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04461-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04461-4","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"conflict of interset Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}